What should you know about PET scans for lung cancer?

PET is commonly combined with CT. CT shows the size and position of a lung nodule, lymph node, or other structure, while PET shows areas using more tracer. This can help clinicians assess lymph nodes and look for disease outside the chest. A scan may also provide a baseline for later comparison.

Tracer uptake is not specific to cancer. Infection and inflammation can also look active, and some tumours may show less uptake. A PET finding therefore guides decisions but does not replace a biopsy when tissue is needed. Brain assessment may require a different type of imaging because normal brain activity can limit PET interpretation there.

Follow instructions about fasting, medicines, water, and diabetes. Tell the team about pregnancy, breastfeeding, recent infection, and any difficulty lying flat. After injection, rest quietly; then remain still during the scan. Results are considered with chest imaging, examination, pathology, and sometimes genomic tumour profiling.

Depending on the findings, the care plan might include surgery such as a lung lobectomy, radiotherapy, chemotherapy, or another systemic treatment. Supportive and palliative care can be added at any stage to help with symptoms and quality of life; it does not mean that cancer treatment must stop.

Tell imaging staff immediately about wheezing, swelling, rash, faintness, or breathing difficulty after the injection. Seek urgent help for severe breathlessness, blue lips, or collapse. Outside the scan appointment, seek prompt medical assessment for new or worsening breathlessness, coughing blood, chest pain, confusion, or weakness.

Ask what the scan is checking, whether a suspicious area needs biopsy, and how the result changes staging. Ask whether the plan depends on tumour markers or genomic testing, and which symptoms should trigger a call while you wait.